DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025
- ALL22728
- 160 Pages
- May 2017
- Diagnostic and Biotech
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. Advantages such as high accuracy & speed, low cost and precise results even from low sample inputs are offered by DNA sequencing over microarray and other genomic analysis methods. The DNA sequencing is also used to execute various applications such as oncology studies, biomarker discovery, forensics, personalized medicine and others. It has also streamlined nucleotide analysis and consists of various widely replaced conventional tools of genomics, especially genotyping, microarray and others. The demand driver of the DNA sequencing market has increased due to surge in sequencing applications and rise in technological advancements in DNA sequencing. The upsurge in the number of genome mapping programs globally and increase in R&D investment drives the global DNA sequencing market.
The global DNA sequencing market is segmented based on product, application, technology, end-user and region. The global DNA sequencing market by product is classified into consumable, instrument and service. The global DNA sequencing market by application is fragmented into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, forensics and others. The global DNA sequencing market by technology is bifurcated into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligaton, pyrosequencing, single molecule real-time sequencing, chain termination sequencing and nanopore sequencing. The global DNA sequencing by end-user is categorized into academic & government research institutes, pharmaceutical companies, biotechnology companies, and hospitals & clinics. The global DNA sequencing market by region is divided into North America, Europe, Asia-Pacific and LAMEA. The global DNA sequencing market based on products the instrument segment is expected to grow at a CAGR of 22.0% during the market forecast period of 2018 to 2025 due to the recent advancements in DNA sequencing instruments. According to the application segment the biomarker & cancer accounted for the highest market share in 2017 owing to the increase in prevalence of cancer across the globe. The Asia-Pacific region possess highest growth potential in the global DNA sequencing market due to increase in awareness about DNA sequencing applications and it is also expected to experience fast-paced growth in terms of development and use of DNA sequencing technologies.
The key players of the global DNA sequencing market include Abbott Laboratories, Agilent Technologies, Inc, Danaher Corporation, F. Hoffmann-La Roche Ltd, Illumina, Inc, LI-COR Biosciences Inc, Pacific Biosciences of California Inc, SIEMENS AG, PerkinElmer Inc, Thermo Fisher Scientific Inc, Eurofins Scientific, Gatc Biotech AG, Macrogen, Inc, Oxford Nanopore Technologies Ltd, Bio-Rad Laboratories Inc, DNASTAR Inc, Biomatters Ltd, New England Biolabs, Inc, and Myriad Genetics Inc.
Key Benefits for DNA Sequencing Market:
- This report entails a detailed quantitative analysis of the current DNA sequencing market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of global DNA sequencing market.
- DNA sequencing market size and estimations are based on a comprehensive analysis of the applications and developments in the DNA sequencing market.
- A quantitative analysis from 2017 to 2025 to enable the stakeholders to capitalize on the prevailing market opportunities is discussed.
- Key market players are profiled, and their strategies are analyzed thoroughly, which help understand the competitive outlook of the market.
- Porter’s five forces model interprets the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition in the key players.
DNA Sequencing Market Segments
By Product
- Consumable
- Instrument
- Service
- By Application
- Diagnostics
- Biomarkers & Cancer
- Reproductive Health
- Personalized Medicine
- Forensics
- Others
- By Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single-molecule Real-time Sequencing
- Chain Termination Sequencing
- Nanopore Sequencing
- By End User
- Academic & Government Research Institutes
- Pharmaceutical Companies
- Biotechnology Companies
- Hospitals & Clinics
- By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Saudi Arabia
- Rest of LAMEA
- North America
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PATENTS ANALYSIS
3.3.1. Patent analysis by year
3.3.2. Patent analysis by region
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET SHARE ANALYSIS
3.5.1. DNA sequencing market share (2012-2017)
3.6. MARKET DYNAMICS
3.6.1. Drivers
3.6.2. Restraints
3.6.3. Opportunities
CHAPTER 4 GLOBAL DNA SEQUENCING MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size & forecast
4.2. CONSUMABLES
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.3. INSTRUMENTS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast
4.4. SERVICES
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size & forecast
CHAPTER 5 GLOBAL DNA SEQUENCING MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size & forecast
5.2. BIOMARKERS AND CANCER
5.2.1. Market size & forecast
5.3. DIAGNOSTICS
5.3.1. Market size & forecast
5.4. REPRODUCTIVE HEALTH
5.4.1. Market size & forecast
5.5. PERSONALIZED MEDICINE
5.5.1. Market size & forecast
5.6. FORENSICS
5.6.1. Market size & forecast
5.7. OTHER APPLICATIONS
5.7.1. Market size & forecast
CHAPTER 6 GLOBAL DNA SEQUENCING MARKET, BY TECHNOLOGY
6.1. OVERVIEW
6.1.1. Market size & forecast
6.2. SEQUENCING BY SYNTHESIS (SBS)
6.2.1. Market size & forecast
6.3. ION SEMICONDUCTOR SEQUENCING (IOS)
6.3.1. Market size & forecast
6.4. SEQUENCING BY LIGATION (SBL)
6.4.1. Market size & forecast
6.5. PYROSEQUENCING
6.5.1. Market size & forecast
6.6. SINGLE-MOLECULE-REAL-TIME SEQUENCING (SMRT)
6.6.1. Market size & forecast
6.7. CHAIN TERMINATION SEQUENCING
6.7.1. Market size & forecast
6.8. NANOPORE SEQUENCING
6.8.1. Market size & forecast
CHAPTER 7 GLOBAL DNA SEQUENCING MARKET, BY END USERS
7.1. OVERVIEW
7.1.1. Market size & forecast
7.2. ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
7.2.1. Market size & forecast
7.3. PHARMACEUTICAL COMPANIES
7.3.1. Market size & forecast
7.4. BIOTECHNOLOGY COMPANIES
7.4.1. Market size & forecast
7.5. HOSPITALS & CLINICS
7.5.1. Market size & forecast
CHAPTER 8 GLOBAL DNA SEQUENCING MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size & forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size & forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size & forecast
8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size & forecast
8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Taiwan market size and forecast
8.4.3.7. Rest of Asia-Pacific market size and forecast
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size & forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. Turkey market size and forecast
8.5.3.3. Saudi Arabia market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. ILLUMINA, INC
9.1.1. Operating business segments
9.1.2. Business performance
9.2. THERMO FISHER SCIENTIFIC, INC
9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments
9.3. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.,
9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments
9.4. SIEMENS AG
9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments
9.5. ZS GENETICS, INC
9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments
9.6. 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG)
9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments
9.7. AGILENT TECHNOLOGIES, INC
9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments
9.8. ABBOTT LABORATORIES
9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments
9.9. BECKMAN COULTER
9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments
9.10. LI-COR
9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL DNA SEQUENCING MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 2. GLOBAL DNA SEQUENCING CONSUMABLES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL DNA SEQUENCING INSTRUMENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL DNA SEQUENCING SERVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL DNA SEQUENCING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 6. BIOMARKERS AND CANCER DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. DIAGNOSTICS DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 8. REPRODUCTIVE HEALTH DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. PERSONALISED MEDICINE NEXT GENERATION SEQUENCING, BY REGION, 2016-2023 ($MILLION)
TABLE 10. FORENSICS DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 11. OTHER APPLICATIONS DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL DNA SEQUENCING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 13. SEQUENCING BY SYNTHESIS TECHNOLOGY DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 14. ION SEMICONDUCTOR SEQUENCING TECHNOLOGY DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. SEQUENCING BY LIGATION TECHNOLOGY DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 16. PYROSEQUENCING TECHNOLOGY DNA SEQUENCING MARKET TECHNOLOGY, BY REGION, 2016-2023 ($MILLION)
TABLE 17. SINGLE-MOLECULE-REAL-TIME-SEQUENCING TECHNOLOGY DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 18. CHAIN TERMINATION DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. NANOPORE DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL DNA SEQUENCING MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 21. ACADEMIC & GOVERNMENT RESEARCH INSTITUTES DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 22. PHARMACEUTICAL COMPANIES DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 23. BIOTECHNOLOGY COMPANIES DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 24. HOSPITALS & CLINICS DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 25. GLOBAL DNA SEQUENCING MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 26. NORTH AMERICA DNA SEQUENCING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 27. NORTH AMERICA DNA SEQUENCING MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 28. NORTH AMERICA DNA SEQUENCING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA DNA SEQUENCING MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 31. EUROPE DNA SEQUENCING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 32. EUROPE DNA SEQUENCING MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 33. EUROPE DNA SEQUENCING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 34. EUROPE DNA SEQUENCING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 35. EUROPE DNA SEQUENCING MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 36. ASIA-PACIFIC DNA SEQUENCING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 37. ASIA-PACIFIC DNA SEQUENCING MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 38. ASIA-PACIFIC DNA SEQUENCING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 39. ASIA-PACIFIC DNA SEQUENCING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 40. ASIA-PACIFIC DNA SEQUENCING MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 41. LAMEA DNA SEQUENCING MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 42. LAMEA DNA SEQUENCING MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 43. LAMEA DNA SEQUENCING MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 44. LAMEA DNA SEQUENCING MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 45. LAMEA DNA SEQUENCING MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 46. ILLUMINA, INC: COMPANY SNAPSHOT
TABLE 47. THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT
TABLE 48. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: COMPANY SNAPSHOT
TABLE 49. SIEMENS AG.: COMPANY SNAPSHOT
TABLE 50. ZS GENETICS, INC.: COMPANY SNAPSHOT
TABLE 51. QIAGEN N.V.: COMPANY SNAPSHOT
TABLE 52. AGILENT TECHNOLOGIES, INC: COMPANY SNAPSHOT
TABLE 53. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 54. BECKMAN COULTER: COMPANY SNAPSHOT
TABLE 55. LI-COR: COMPANY SNAPSHOT
LIST OF FIGURES
FIGURE 1. TOP INVESTMENT POCKETS: GLOBAL DNA SEQUENCING MARKET, BY APPLICATION
FIGURE 2. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 4. PATENT ANALYSIS BY REGION
FIGURE 5. BARGAINING POWER OF BUYERS
FIGURE 6. BARGAINING POWER OF SUPPLIERS
FIGURE 7. THREAT OF NEW ENTRANTS
FIGURE 8. THREAT OF SUBSTITUTION
FIGURE 9. COMPETITIVE RIVALRY
FIGURE 10. MARKET SHARE ANALYSIS
FIGURE 11. DNA SEQUENCINGMARKET: PRODUCT SEGMENATION
FIGURE 12. U.S. DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 13. CANADA DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 14. MEXICO DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 15. GERMANY DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 16. FRANCE DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 17. UK DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 18. ITALY DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 19. SPAIN DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 20. REST OF EUROPE DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 21. JAPAN DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 22. CHINA DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 23. AUSTRALIA DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 24. INDIA DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 25. SOUTH KOREA DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 26. TAIWAN DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 27. REST OF ASIA-PACIFIC DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 28. BRAZIL DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 29. TURKEY DNA SEQUENCING MARKET, 2016-20223 ($MILLION)
FIGURE 30. SAUDI ARABIA DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 31. REST OF LAMEA DNA SEQUENCING MARKET, 2016-2023 ($MILLION)
FIGURE 32. ILLUMINA, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 33. ILLUMINA, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 34. THERMO FISHER SCIENTIFIC, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 35. THERMO FISHER SCIENTIFIC, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 36. THERMO FISHER SCIENTIFIC, INC: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 37. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: NET SALES, 2014-2017 ($MILLION)
FIGURE 38. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: REVENUE BY SEGMENT, 2015 (%)
FIGURE 39. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 40. SIEMENS AG.: NET SALES, 2014-2017 ($MILLION)
FIGURE 41. SIEMENS AG.: REVENUE BY SEGMENT, 2015 (%)
FIGURE 42. SIEMENS AG.: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 43. ZS GENETICS, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 44. ZS GENETICS, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 45. ZS GENETICS, INC: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 46. 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG): NET SALES, 2014-2017 ($MILLION)
FIGURE 47. 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG): REVENUE BY SEGMENT, 2015 (%)
FIGURE 48. 454 LIFE SCIENCES CORPORATION (ROCHE HOLDING AG): REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 49. AGILENT TECHNOLOGIES, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 50. AGILENT TECHNOLOGIES, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 51. AGILENT TECHNOLOGIES, INC: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 52. ABBOTT LABORATORIES: NET SALES, 2014-2017 ($MILLION)
FIGURE 53. ABBOTT LABORATORIES: REVENUE BY SEGMENT, 2015 (%)
FIGURE 54. ABBOTT LABORATORIES: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 55. BECKMAN COULTER: NET SALES, 2014-2017 ($MILLION)
FIGURE 56. BECKMAN COULTER: REVENUE BY SEGMENT, 2015 (%)
FIGURE 57. BECKMAN COULTER: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 58. LI-COR: NET SALES, 2014-2017 ($MILLION)
FIGURE 59. LI-COR: REVENUE BY SEGMENT, 2015 (%)
FIGURE 60. LI-COR: REVENUE BY GEOGRAPHY, 2015 (%)
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
